About Eurofins DiscoverX Our Expertise in Your Hands – Discover Confidently. For drug discovery and development scientists, Eurofins DiscoverX is the trusted product solutions provider that can accelerate your programs with confidence with qualified reagents, cell lines, and assays ready to run today.
July 22, 2020: Eurofins DiscoverX Products Now Available Through Fisher Scientific June 29, 2020: Eurofins DiscoverX Grants Bioassay Certification to Catalent Biologics Conferences 2021 Conferences Coming Soon Webinars & Videos Knowledge-Based Videos COVID-19/Cytotokine Assays Webinar, Eurofins DiscoverX Applications and Products Eurofins DiscoverX is committed to enabling and accelerating your multi-modality drug discovery and development from discovery to QC lot release by providing you the broadest and most comprehensive collections of qualified reagents, biochemical and cell-based assays, cell lines, and custom assay development services.
Eurofins DiscoverX Products. In addition to our >3,500 drug discovery services, Eurofins Discovery offers a broad range of products to support your in-house drug discovery projects through our products brand of Eurofins DiscoverX . Access >1,800 of the same high quality and robust drug discovery products that we developed to use in our services.
GitHub is where Eurofins Discovery builds software. Analytics cookies. We use analytics cookies to understand how you use our websites so we can make them better, e.g. they’re used to gather information about the pages you visit and how many clicks you need to accomplish a task.
Eurofins Pharma Discovery Services is a contract research organization that provides drug discovery services to pharma and biotech companies worldwide.
Whether you are developing small molecule or biologic therapeutic drugs, Eurofins DiscoverX provides you with a variety of drug discovery products with multiple assay types to meet your specific GPCR research needs. Broad Coverage – >90% targets covered across the human GPCRome to always find an assay for your target of interest, Eurofins Discovery Services and Eurofins DiscoverX use a variety of target, phenotypic, and pathway based approaches to enable you to make better cancer immunotherapies, faster. Watch the webinar, Enabling Development of Cancer Immunotherapy Drugs .
Developing and validating cell-based assays during drug discovery is expensive and can take months to complete. However, data is needed in days or weeks instead of months. To help meet aggressive timelines, Eurofins Discovery’s GPCR Services provides over 1800 assays to address your Screening, Profiling and Safety Pharmacology needs.
Eurofins DiscoverX is the leading supplier of innovative cell-based assays and services for drug discovery and development. Strong leadership fosters an environment of innovation and encourages a commitment towards integrity and success.
